American Healthcare REIT, Inc. (AHR)
(Delayed Data from NYSE)
$16.46 USD
+0.15 (0.92%)
Updated Jul 19, 2024 04:00 PM ET
4-Sell of 5 4
B Value D Growth D Momentum C VGM
Income Statements
Fiscal Year end for American Healthcare REIT, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,867 | 1,643 | 1,282 | 155 | 121 |
Cost Of Goods | 1,560 | 1,341 | 1,069 | 84 | 57 |
Gross Profit | 307 | 302 | 213 | 71 | 64 |
Selling & Adminstrative & Depr. & Amort Expenses | 236 | 216 | 189 | 67 | 63 |
Income After Depreciation & Amortization | 71 | 86 | 24 | 5 | 1 |
Non-Operating Income | 17 | -54 | -4 | -3 | 0 |
Interest Expense | 164 | 105 | 89 | 21 | 21 |
Pretax Income | -76 | -73 | -52 | -19 | -19 |
Income Taxes | 1 | 1 | 1 | 0 | 0 |
Minority Interest | -5 | 8 | -5 | -1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -77 | -73 | -53 | -19 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -71 | -81 | -48 | -18 | -19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 319 | 310 | 181 | 58 | 50 |
Depreciation & Amortization (Cash Flow) | 248 | 224 | 157 | 53 | 49 |
Income After Depreciation & Amortization | 71 | 86 | 24 | 5 | 1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 66.05 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.08 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.08 | -1.24 | -0.24 | -0.22 | -0.24 |
Fiscal Year end for American Healthcare REIT, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 499.53 | 482.58 | 464.24 | 467.57 |
Cost Of Goods | NA | 417.36 | 398.07 | 389.18 | 387.20 |
Gross Profit | NA | 82.18 | 84.52 | 75.06 | 80.37 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 57.38 | 58.85 | 61.64 | 57.36 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 24.80 | 25.67 | 13.42 | 23.01 |
Non-Operating Income | NA | 2.50 | 4.10 | 19.02 | 1.47 |
Interest Expense | NA | 30.02 | 50.31 | 38.60 | 36.00 |
Pretax Income | NA | -2.73 | -31.07 | -6.16 | -11.52 |
Income Taxes | NA | 0.28 | -0.11 | 0.28 | 0.35 |
Minority Interest | NA | 0.89 | -3.53 | -0.46 | 0.32 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.00 | -30.96 | -6.45 | -11.87 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.89 | -27.43 | -5.99 | -12.18 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 104.30 | 66.08 | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.04 | -0.42 | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.04 | -0.41 | -0.09 | -0.19 |